Triazolone derivatives

Details Triazolone derivatives Triazolone derivatives

2007-03-22

2010-10-19

Chung, Susannah (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Four or more ring nitrogens in the bicyclo ring system

C546S184000, C548S255000, C548S262200, C548S356100, C548S300100, C548S400000

Reexamination Certificate

active

07816522

ABSTRACT:
A Compound represented by the following general formula (1), salts thereof or hydrates of the foregoing is a novel compound useful for treatment and/or prevention of diseases associated with thrombus formation, and which is safer with suitable physicochemical stability.[wherein R1a, R1b, R1cand R1deach independently represent hydrogen, etc.; R2represents optionally substituted phenyl, etc.; R3represents optionally substituted C6-10 aryl, etc.; and Z1and Z2each independently represent hydrogen]

REFERENCES:
patent: 6916837 (2005-07-01), Satoh et al.
patent: 7576098 (2009-08-01), Glunz et al.
patent: 2002/0004608 (2002-01-01), Alig et al.
patent: 2002/0052417 (2002-05-01), Klingler et al.
patent: 2003/0181766 (2003-09-01), Satoh et al.
patent: 2004/0242627 (2004-12-01), Suzuki et al.
patent: 2004/0254376 (2004-12-01), Suzuki et al.
patent: 2005/0004197 (2005-01-01), Suzuki et al.
patent: 2005/0004204 (2005-01-01), Suzuki et al.
patent: 2005/0245592 (2005-11-01), Suzuki et al.
patent: 2008/0015199 (2008-01-01), Clark et al.
patent: 2008/0132507 (2008-06-01), Clark et al.
patent: 2009/0270433 (2009-10-01), Clark et al.
patent: 58281/80 (1980-11-01), None
patent: 0 019 586 (1980-11-01), None
patent: 1 020 434 (2000-07-01), None
patent: 1 078 917 (2001-02-01), None
patent: 1 312 602 (2003-05-01), None
patent: 1 828 152 (2007-09-01), None
patent: 2002-509924 (2002-04-01), None
patent: 2002-543176 (2002-12-01), None
patent: 2003-212837 (2003-07-01), None
patent: 2003-534311 (2003-11-01), None
patent: 2003-535844 (2003-12-01), None
patent: 1512055 (1992-07-01), None
patent: WO-99/10316 (1999-03-01), None
patent: WO-99/41231 (1999-08-01), None
patent: WO-99/50255 (1999-10-01), None
patent: WO-00/35858 (2000-06-01), None
patent: WO-00/41531 (2000-07-01), None
patent: WO-00/58346 (2000-10-01), None
patent: WO 00/58346 (2000-10-01), None
patent: WO-00/66545 (2000-11-01), None
patent: WO-02/085855 (2002-10-01), None
patent: WO-2004/032846 (2004-04-01), None
patent: WO-2004/101555 (2004-11-01), None
patent: WO-2006/041119 (2006-04-01), None
patent: WO-2006/062972 (2006-06-01), None
patent: WO 2007/111212 (2007-10-01), None
Roussel et al., “Inhibition of the Tissue Factor/Factor VIIa Complex—Lead Optimisation Using Combinatorial Chemistry,” Tetrahedron, vol. 55, pp. 6219-6230 (1999).
Database WPI Week 199323, Thomson Scientific, London, GB 1993-186830, XP002540626.
Vippagunta et al., “Crystalline Solids,”Adv. Drug Delivery Rev., 48, pp. 3-26 (2001).
McMahon et al., “VEGF Receptor Signaling in Tumor Angiogenesis,”The Oncologist, 5 (suppl 1): pp. 3-10 (2000).
Fu et al., “Anti-apoptotic role . . . ,”Biochemical and Biophysical Research Comm., 349, pp. 504-512 (2006).
Pinedo et al., “Translational Research . . . ,”The Oncologist, 5 (suppl 1): pp. 1-2 (2000).
Office Action of Jun. 24, 2009 in U.S. Appl. No. 11/665,385.
“Cancer.” Medline Plus. (2009). Accessed Mar. 17, 2009. <http://www.nlm.nih.gov/medlineplus/cancer.html>.
Golub et al. “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring.” Science (1999), vol. 286, 521-537.
Lala et al. “Role of nitric oxide in tumor progression: Lessons form experimental tumors.” Cancer and Metastasis Reviews (1998), 17(1), 91-106.
Notice of Allowance of Feb. 23, 2010 in U.S. Appl. No. 11/665,385.
Notice of Allowance of Feb. 23, 2010 in U.S. Appl. No. 12/234,116.
International Preliminary Report on Patentability (Forms PCT/IB/338 and PCT/IB/373) and Written Opinion of the International Searching Authority (Form PCT/ISA/327) issued Apr. 15, 2010, in International Application No. PCT/JP2008/066944.

Affiliated with

Also associated with

Rating

Triazolone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triazolone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolone derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4185324